Quotient Ltd·4

Feb 25, 4:05 PM ET

von Prondzynski Heino 4

4 · Quotient Ltd · Filed Feb 25, 2022

Insider Transaction Report

Form 4
Period: 2022-02-23
Transactions
  • Purchase

    Ordinary Shares

    2022-02-24$1.31/sh+28,894$37,851371,359 total
  • Purchase

    Ordinary Shares

    2022-02-23$1.28/sh+31,106$39,816342,465 total
Holdings
  • Ordinary Share Option (Right to Buy)

    Exercise: $5.73Exp: 2026-10-31Ordinary Shares (8,726 underlying)
    8,726
  • Restricted Stock Units

    Ordinary Shares (17,260 underlying)
    51,781
  • Ordinary Shares Option (Right to buy)

    Exercise: $5.21Exp: 2027-10-31Ordinary Shares (9,597 underlying)
    9,597
  • Ordinary Share Option (Right to Buy)

    Exercise: $11.62Exp: 2025-10-31Ordinary Shares (4,303 underlying)
    4,303
Footnotes (5)
  • [F1]Restricted Stock Units convert into ordinary shares on a one-for-one basis.
  • [F2]All 4,303 options have vested and remain exercisable.
  • [F3]All 8,726 options have vested and remain exercisable.
  • [F4]All 9,597 options have vested and remain exercisable.
  • [F5]On October 31, 2021, the Reporting Person was granted 69,041 restricted stock units, of which 17,260 have vested and have converted into ordinary shares. The remaining 51,781 restricted stock units will vest in three equal installments on April 30, 2022, July 31, 2022 and October 31, 2022.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION